Business
Press Release Sep 01 2022
Strides Pharma Science Limited has informed the Exchange about press release dated 01-Sep-2022 titled Stelis Biopharma���s flagship facility receives USFDA nod for Drug Product Capabilities
About this update from Strides Pharma Science Ltd
[{"type":"text","content":" Strides Pharma Science Limited has informed the Exchange about press release dated 01-Sep-2022 titled Stelis Biopharma���s flagship facility receives USFDA nod for Drug Product Capabilities View Attachment","length":337,"tagName":"div"}]